(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 10.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 187.5%.
Lensar's revenue in 2026 is $58,435,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $777,882,125, with the lowest LNSR revenue forecast at $707,666,987, and the highest LNSR revenue forecast at $843,307,393.
In 2027, LNSR is forecast to generate $1,100,508,891 in revenue, with the lowest revenue forecast at $1,057,351,679 and the highest revenue forecast at $1,132,876,799.